Dawn Svoronos, Director at Adverum Biotechnologies, Inc. (ADVM), bought 20,000 shares at $10.02 ($200K) on 2021-03-31, disclosed to the SEC on 2021-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GBT | SELL | 2022-06-22 | $104K | — | Filing → |
| PTCT | SELL | 2022-06-10 | $20K | — | Filing → |
| ADVM | BUY | 2022-05-18 | $26K | — | Filing → |